Harnessing a T1 Phage-Derived Spanin for Developing Phage-Based Antimicrobial Development
The global increase in the prevalence of drug-resistant bacteria has necessitated the development of alternative treatments that do not rely on conventional antimicrobial agents. Using bacteriophage-derived lytic enzymes in antibacterial therapy shows promise; however, a thorough comparison and eval...
Main Authors: | Wakana Yamashita, Shinjiro Ojima, Azumi Tamura, Aa Haeruman Azam, Kohei Kondo, Zhang Yuancheng, Longzhu Cui, Masaki Shintani, Masato Suzuki, Yoshimasa Takahashi, Koichi Watashi, Satoshi Tsuneda, Kotaro Kiga |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS)
2024-01-01
|
Series: | BioDesign Research |
Online Access: | https://spj.science.org/doi/10.34133/bdr.0028 |
Similar Items
-
Phage spanins: diversity, topological dynamics and gene convergence
by: Rohit Kongari, et al.
Published: (2018-09-01) -
Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages
by: Bi-o Kim, et al.
Published: (2019-03-01) -
Harnessing filamentous phages for enhanced stroke recovery
by: Yang Li, et al.
Published: (2024-01-01) -
Biological properties of Staphylococcus virus ΦSA012 for phage therapy
by: Jumpei Fujiki, et al.
Published: (2022-12-01) -
Bacteriophages as Solid Tumor Theragnostic Agents
by: Srivani Veeranarayanan, et al.
Published: (2021-12-01)